BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22506047)

  • 1. Activation of cell cycle arrest and apoptosis by the proto-oncogene Pim-2.
    Levy D; Davidovich A; Zirkin S; Frug Y; Cohen AM; Shalom S; Don J
    PLoS One; 2012; 7(4):e34736. PubMed ID: 22506047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PIM-2 kinase is an essential component of the ultraviolet damage response that acts upstream to E2F-1 and ATM.
    Zirkin S; Davidovich A; Don J
    J Biol Chem; 2013 Jul; 288(30):21770-83. PubMed ID: 23760264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.
    Koida N; Ozaki T; Yamamoto H; Ono S; Koda T; Ando K; Okoshi R; Kamijo T; Omura K; Nakagawara A
    J Biol Chem; 2008 Mar; 283(13):8555-63. PubMed ID: 18174154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Pim-3 suppresses the tumorigenicity of glioblastoma by regulating cell cycle and apoptosis.
    Quan J; Zhou L; Qu J
    Cell Mol Biol (Noisy-le-grand); 2015 Mar; 61(1):42-50. PubMed ID: 25817345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widdrol activates DNA damage checkpoint through the signaling Chk2-p53-Cdc25A-p21-MCM4 pathway in HT29 cells.
    Yun HJ; Hyun SK; Park JH; Kim BW; Kwon HJ
    Mol Cell Biochem; 2012 Apr; 363(1-2):281-9. PubMed ID: 22160829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein.
    Matallanas D; Romano D; Yee K; Meissl K; Kucerova L; Piazzolla D; Baccarini M; Vass JK; Kolch W; O'neill E
    Mol Cell; 2007 Sep; 27(6):962-75. PubMed ID: 17889669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects.
    Ionov Y; Le X; Tunquist BJ; Sweetenham J; Sachs T; Ryder J; Johnson T; Lilly MB; Kraft AS
    Anticancer Res; 2003; 23(1A):167-78. PubMed ID: 12680209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma.
    Yang Q; Chen LS; Neelapu SS; Miranda RN; Medeiros LJ; Gandhi V
    Blood; 2012 Oct; 120(17):3491-500. PubMed ID: 22955922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1).
    Kreis NN; Sommer K; Sanhaji M; Krämer A; Matthess Y; Kaufmann M; Strebhardt K; Yuan J
    Cell Cycle; 2009 Feb; 8(3):460-72. PubMed ID: 19177004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
    de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
    J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
    Ray RM; Bhattacharya S; Johnson LR
    Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells.
    Wang Z; Zhang Y; Gu JJ; Davitt C; Reeves R; Magnuson NS
    Int J Biochem Cell Biol; 2010 Jun; 42(6):1030-8. PubMed ID: 20307683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1.
    Soond SM; Barry SP; Melino G; Knight RA; Latchman DS; Stephanou A
    Cell Cycle; 2008 May; 7(9):1214-23. PubMed ID: 18418051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated expression of E2F1 promotes proteolytic degradation of tumor suppressor p73 and inhibits its transcriptional activity.
    Ozaki T; Okoshi R; Ono S; Kubo N; Nakagawara A
    Biochem Biophys Res Commun; 2009 Sep; 387(1):143-8. PubMed ID: 19576172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.
    Emmrich S; Wang W; John K; Li W; Pützer BM
    Mol Cancer; 2009 Aug; 8():61. PubMed ID: 19671150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils.
    Stout BA; Bates ME; Liu LY; Farrington NN; Bertics PJ
    J Immunol; 2004 Nov; 173(10):6409-17. PubMed ID: 15528381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
    Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
    Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.